These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Mutagenicity in urine of nurses handling cytostatic drugs. Falck K; Gröhn P; Sorsa M; Vainio H; Heinonen E; Holsti LR Lancet; 1979 Jun; 1(8128):1250-1. PubMed ID: 87722 [No Abstract] [Full Text] [Related]
3. Risk of handling injectable antineoplastic agents. Anderson RW; Puckett WH; Dana WJ; Nguyen TV; Theiss JC; Matney TS Am J Hosp Pharm; 1982 Nov; 39(11):1881-7. PubMed ID: 6756133 [TBL] [Abstract][Full Text] [Related]
4. Limitations of urinary mutagen assays for monitoring occupational exposure to antineoplastic drugs. Tuffnell PG; Gannon MT; Dong A; DeBoer G; Erlichman C Am J Hosp Pharm; 1986 Feb; 43(2):344-8. PubMed ID: 3513557 [TBL] [Abstract][Full Text] [Related]
5. Antineoplastic drugs and spontaneous abortion in nurses. N Engl J Med; 1986 Apr; 314(16):1048-51. PubMed ID: 3960073 [No Abstract] [Full Text] [Related]
6. Handle with care. Darbyshire P Nurs Times; 1986 Oct 1-7; 82(40):37-8. PubMed ID: 3640402 [No Abstract] [Full Text] [Related]
7. Occupational exposure to antineoplastic agents: self-reported miscarriages and stillbirths among nurses and pharmacists. Valanis B; Vollmer WM; Steele P J Occup Environ Med; 1999 Aug; 41(8):632-8. PubMed ID: 10457505 [TBL] [Abstract][Full Text] [Related]
8. The predictability of bioassays. Anderson D Prog Clin Biol Res; 1982; 109():149-68. PubMed ID: 6891964 [No Abstract] [Full Text] [Related]
9. Bacterial urinary assay in monitoring exposure to mutagens and carcinogens. Vainio H; Sorsa M; Falck K IARC Sci Publ; 1984; (59):247-58. PubMed ID: 6400094 [TBL] [Abstract][Full Text] [Related]
10. Re-evaluation of urine mutagenicity of pharmacy personnel exposed to antineoplastic agents. Connor TH; Theiss JC; Anderson RW; Puckett WH; Matney TS Am J Hosp Pharm; 1986 May; 43(5):1236-9. PubMed ID: 3521267 [No Abstract] [Full Text] [Related]
11. Occupational exposure to anticancer drug--potential and real hazards. Sorsa M; Hemminki K; Vainio H Mutat Res; 1985 Sep; 154(2):135-49. PubMed ID: 3929080 [TBL] [Abstract][Full Text] [Related]
12. Hospital personnel who handle anticancer drugs may face risks. Macek C JAMA; 1982 Jan; 247(1):11-2. PubMed ID: 7053428 [No Abstract] [Full Text] [Related]
13. Comparison of methods for the biomonitoring of nurses handling antitumor drugs. Thiringer G; Granung G; Holmén A; Högstedt B; Järvholm B; Jönsson D; Persson L; Wahlström J; Westin J Scand J Work Environ Health; 1991 Apr; 17(2):133-8. PubMed ID: 2047815 [TBL] [Abstract][Full Text] [Related]
14. [Nurses' exposure to cytostatics in the handling of cytostatics. Theoretical lesson and clinical study]. Johansson I; Bergenfelz A; Wadbo M SHSTF; 1981 Aug; (7):1-29. PubMed ID: 6914812 [No Abstract] [Full Text] [Related]
15. Detection of low levels of urinary mutagen excretion by chemotherapy workers which was not related to occupational drug exposures. Everson RB; Ratcliffe JM; Flack PM; Hoffman DM; Watanabe AS Cancer Res; 1985 Dec; 45(12 Pt 1):6487-97. PubMed ID: 4063994 [TBL] [Abstract][Full Text] [Related]
16. How real is the hazard? Lancet; 1984 Jan; 1(8370):203. PubMed ID: 6141342 [No Abstract] [Full Text] [Related]
17. Urinary mutagenicity assays: a problem arising from the presence of histidine associated growth factors in XAD-2 prepared urine concentrates, with particular relevance to assays carried out using the bacterial fluctuation test. Gibson JF; Baxter PJ; Hedworth-Whitty RB; Gompertz D Carcinogenesis; 1983 Nov; 4(11):1471-6. PubMed ID: 6357523 [TBL] [Abstract][Full Text] [Related]
18. Genetic risks caused by occupational chemicals. Use of experimental methods and occupational risk group monitoring in the detection of environmental chemicals causing mutations, cancer and malformations. Hemminki K; Sorsa M; Vainio H Scand J Work Environ Health; 1979 Dec; 5(4):307-27. PubMed ID: 395639 [No Abstract] [Full Text] [Related]
19. Limitations of the salmonella/mammalian microsome assay (Ames test) to determine occupational exposure to cytostatic drugs. Friederich U; Molko F; Hofmann V; Scossa D; Hann D; Würgler FE; Senn HJ Eur J Cancer Clin Oncol; 1986 May; 22(5):567-75. PubMed ID: 3533554 [TBL] [Abstract][Full Text] [Related]
20. Inhalation anesthetics, anticancer drugs and sterilants as chemical hazards in hospitals. Vainio H Scand J Work Environ Health; 1982 Jun; 8(2):94-107. PubMed ID: 7134932 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]